Fibrous scaffolds as carrier matrices for printed drug delivery systems – Presented by Mirja Palo, Pharmaceutical Sciences Laboratory, Åbo Akademi University

Fibrous scaffolds as carrier matrices for printed drug delivery systems – Presented by Mirja Palo, Pharmaceutical Sciences Laboratory, Åbo Akademi University at The 3D Medicine & Pharmaceutical Printing Conference which will take place on  Feb 01, 2017 at MECC Maastricht in The Netherlands.

For the last decades, printing technology has been intensively investigated with the aim to provide suitable fabrication methods for individualized drug therapy. Printed drug delivery systems that are produced on-demand provide flexibility in dosage form design while maintaining high accuracy for personalized dosing. Substrate materials allow the tailoring of dosage forms for specific route of administration and control the drug release. This presentation introduces an approach to produce solid dosage forms on electrospun fibrous matrices with inkjet printing as the drug deposition method. An overview on the characteristic properties of the prepared oromucosal formulations will be presented. Also the general use of printing technologies in manufacturing of drug delivery systems is discussed.

About Mirja Palo
Mirja Palo received her MSc (Pharm) diploma in 2012 from University of Tartu. Currently she is a PhD researcher in pharmaceutical sciences with a collaboration project between Åbo Akademi University (Finland) and University of Tartu (Estonia). Her doctoral research focuses on the applications of printing technologies for the personalized medicines and the solid state characterization of the printed pharmaceuticals.

About Pharmaceutical Sciences Laboratory, Åbo Akademi University 
The Pharmaceutical Sciences Laboratory is part of the Faculty of Science and Engineering at Åbo Akademi University. Mirja Palo is conducting her research in the Drug-Delivery and Pharmaceutical Technology Research Group coordinate by Prof. Niklas Sandler.

Leave a Reply

Your email address will not be published.